Logo
Search

Rules:

Only words with 2 or more characters are accepted
Max 200 chars total
Space is used to split words, "" can be used to search for a whole string (not indexed search then)
AND, OR and NOT are prefix words, overruling the default operator
+/|/- equals AND, OR and NOT as operators.
All search words are converted to lowercase.

Search for "safety"

Displaying results 1 to 10 out of 11

  News 4 81%
  ... for an oncological treatment Known critical cardiac safety profile according to the SMPC Clinical conduct in 6 ... of external specialists (cardiologists) for cardiac safety assesments and provison of a Data Safety Monitoring Board Adaptive trial design to combine ... IV dosing procedure to ensure tolerability and
  Size: 30 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Home/News 4

  Trial Expertise 70%
  ... after last subject dosed in a particular dose group. Safety and tolerability Suitable study measures and profiles ... and clinical data on the molecule. Cardiac safety trials in healthy subjects and patients About 3–5 trials annually are cardiac safety trials. In some cases CRS cooperates with a central ... range of genotyped subjects . Thorough QTc/cardiac
  Size: 35 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Expertise/Trial Expertise

  Consultancy 69%
  ... plans both in early and late-stage development Scientific advice meetings IND filing/CTA filing Integrated summaries on efficacy and safety regulatory meetings and representation End-of-Phase II meetings
  Size: 30 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Services/Consultancy

  Partners 67%
  ... Forschung GmbH www.lkf-kiel.de Services Local safety lab provide & central lab services in multicentre ... Labs Mönchengladbach GmbH www.mlm-labs.com Services Safety lab provider Facts Est. 1993 Headcount: 20 ... Dr. Schmitt & Partner http://www.lab-kl.de Services Safety lab provider Facts Est 1974 Headcount: 130 ... centralised core laboratory for cardiac
  Size: 44 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /CRS/Partners

  Locations 65%
  ... experienced in complex ECG trial designs. Mönchengladbach The CPU with 54 beds is specialised in trials regarding men's & women's health, skin safety, cardiovascular diseases and nutritionals. Mannheim The largest CPU with 102 beds provides special expertise in respiratory research and in ...
  Size: 33 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Locations

  Home 62%
  ... trials? CRS's excellent track record is based on four decades of experience in clinical research, and the very highest standards of quality and safety. Click  here to see our latest Press Release. Services CRS is a leading European full-service contract research organisation (CRO). It offers ...
  Size: 36 K - Created: 18-11-12 - Modified: 13-07-17 15:31
Path: /Home

  In a Nutshell 62%
  ... impairment Respiratory / inhalative devices Women's health / gynaecological examinations Men's health Dermal & transdermal application Skin safety, sensitisation & photo-toxicity Opioids Large Pool of Volunteers and Patients Male & female Different age groups (incl. 85 years and over) ...
  Size: 31 K - Created: 12-08-15 - Modified: 13-07-17 15:29
Path: /CRS/In a Nutshell

  Mönchengladbach 59%
  ... trials (overnight stays up to 46 days) combined with challenging PK and PD schedules. In addition, the unit has special expertise in skin safety testing, cardiovascular related trials and the conduct of studies with pre- and postmenopausal women as well as in FIM. Infrastructure & ...
  Size: 32 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Locations/Mönchengladbach

  2010-2017 57%
  ... M , Yong CL, Elgadi M., Pharmacokinetics, safety, and tolerability of faldaprevir in patients with ... KE, Faisst N, Hinrichsen H. Pharmacokinetics and safety of teneligliptin in subjects with hepatic impairment. ... E, William L. Heyward,J. Tyler Martin. Comparison of safety and immunogenicity of two doses of investigational ... William L Heyward, J Tyler Martin . Comparison of
  Size: 65 K - Created: 09-11-15 - Modified: 27-07-17 10:05
Path: /Expertise/Published Expertise/2010-2017

  2000 – 2009 56%
  ... on the pharmacokinetics, pharmacodynamics, and safety of tezosentan. J Clin Pharmacol 2009; 49(4):455-464. ... with monophosphoryl lipid A (MPL®): preliminary safety, efficacy and immunogenicity results. The journal of ... 2008), November 6-8, 2008, Berlin. Timmer W. Cardiac Safety – Dr Wolfgang Timmer of CRS examines the conduct of ... V, Tzatzaris M, Merkl K, Wulff N, Chaplin P.
  Size: 53 K - Created: 09-11-15 - Modified: 20-06-17 17:09
Path: /Expertise/Published Expertise/2000 – 2009

FooterEnd